Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Who saw the news on Providence Therapeutics today

<< Previous

Bullboard Posts

Next >>

Comment by Eoganachton Sep 14, 2021 11:53am

233 Views

Post# 33855021

RE:RE:RE:RE:RE:RE:Who saw the news on Providence Therapeutics today

You're welcome Enrique. I couldn't find out anything about Sanofi and TLD1433, but I seem to remember somebody joking a few years back about Sanofi stopping manufacturing BCG and then making up for it by manufacturing TLD1433.

enriquesuave wrote:
Thanks Eoganacht, I always thought it was Sanofi for some reason.

Eoganacht wrote: That wasn't quite right. It's on page 10 & 11 of the MD&A and Theralase is paying Alphora $939,000, which is more in line with what Theralsse has reported in the past they paid for a large batch of TLD1433.

Eoganacht wrote: In the recent MD&A on page 16 it says Theralase is paying over $400,000 to a company called Alphora Research Inc. in Mississauga. According to their website, Alphora provides API (Active Pharmaceutical Ingredient) technology development services for the scale-up of complex small molecules for Pharmaceutical and Biotechnology Companies. it sounds like they may be producing TLD1433 to Theralase.

enriquesuave wrote: Can someone confirm that TLD-1433 is manufactured by Sanofi still? Any link to this info ? Thanks